首页> 外文会议>Society for Biomaterials Annual Meeting and Exposition >Silver Nanoparticle-Embedded Polymersome Nanocarriers for the Treatment of Antibiotic-Resistant Infections
【24h】

Silver Nanoparticle-Embedded Polymersome Nanocarriers for the Treatment of Antibiotic-Resistant Infections

机译:银纳米粒子嵌入聚合物纳米载体用于治疗抗生素抗性感染

获取原文

摘要

This work has many important implications. A dual-mechanism, concentrated treatment in one particle able to overcome antibiotic resistance would be extremely beneficial in the clinic. Importantly, this treatment does not rely on the discovery of a new pharmaceutical compound, which would be extremely expensive to commercialize. Instead, the efficacy of an existing antibiotic is restored by exploiting a synergistic combination with hydrophobic silver nanoparticles and nano-encapsulation. The absence of effect from the AgPs-Amp is a promising sign for limiting the toxicity from the silver nanoparticles themselves. Finally, the designed particle is also easily customizable, allowing for the potential of personalized infection treatments. The authors envision a scenario where a combination of different antibiotics and/or antimicrobial compounds could be loaded into the AgPs designed to optimally treat a patient's specific infection.
机译:这项工作具有许多重要的影响。一种能够克服抗生素抗性的一种粒子中的双机构,浓缩处理将在临床中非常有益。重要的是,这种治疗不依赖于新的药物化合物的发现,这对商业化非常昂贵。相反,通过利用与疏水银纳米粒子和纳米包封的协同组合来恢复现有抗生素的疗效。没有来自AGPS-AMP的效果是有希望的标志,用于限制银纳米颗粒本身的毒性。最后,设计的粒子也很容易可定制,允许个性化感染治疗的潜力。作者设想了一种场景,其中不同抗生素和/或抗微生物化合物的组合可以装载到旨在最佳地治疗患者的特异性感染的AGPS中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号